… as promising targets for the development of new therapies in many types of cancer. In the
present review, the leading factors involved in cervical cancer development were investigated, …

… cervical cancer (CC) is the fourth most common cancer in women worldwide after breast,
colorectal, and lung cancers… disease and development of prophylaxis and therapy against such. …

… development of immunotherapeutic approaches for the prevention and treatment of cervical
cancer… Individuals with CIN2/3 are at a high risk for developing cervical cancer if left …

… The development of new PET tracers targeting hypoxic response is essential because we
are now in the era of rationally designed molecularly targeted therapies combined with CRT, …

… in cancer development, progression, and therapeutic response … In particular, tumor-specific
immune responses, as well as … inflammatory responses, have been correlated with treatment-…

… Obstetrics (FIGO) stages of cervical cancer development. It was identified that … cervical
cancer development. The results indicated that DEmiRNAs in different stages of cervical cancer …

… Most women who develop cervical cancer have not been screened for at … response to clear
the virus-infected cells from their cervix. In most instances, two consecutive positive screening …

… IVB) or have, after primary treatment, pelvic recurrence, distant … At this stage, cervical cancer
is even more difficult to treat … tumor progression and previous therapies; thus, the tumor at …

… -stage cervical cancer. The purposes of the study were to evaluate the treatment response,
… experienced either tumor remission or tumor progression and it was withdrawn if patients …

… of CD4+ T cells and the disorder of CD4+/CD8+ ratio are all related to rapid tumor growth
and lymph node infiltration of cervical cancer. The higher level of CD4+ T lymphocytes at the …